International Strategies for Tropical Disease Treatments - Experiences with Praziquantel - EDM Research Series No. 026
(1998; 113 pages) View the PDF document
Table of Contents
View the documentAbstract
View the documentAcknowledgments
View the documentInformation on authors
View the documentExchange rates used in the report
Open this folder and view contentsChapter 1: Policies for praziquantel*
Open this folder and view contentsChapter 2: Bayer & E. Merck: Discovery and development of praziquantel*
Open this folder and view contentsChapter 3: Shin Poong Pharmaceutical Co.: Process development in the Republic of Korea*
Close this folderChapter 4: The Egyptian International Pharmaceutical Industries Co.: Praziquantel formulation*
View the documentHistory of EIPICO’s development
View the documentSchistosomiasis in Egypt
View the documentPraziquantel production
View the documentReferences
Open this folder and view contentsChapter 5: The international supply of praziquantel*
Open this folder and view contentsChapter 6: Demand for praziquantel and national distribution*
Open this folder and view contentsChapter 7: Prices and production costs of praziquantel*
View the documentOther documents in the DAP Research Series
View the documentDAP Research Series No. 26
 

References

Barakat, R., A.G. El Masry, A. Farghaly, et al., “Impact of Population-Based Selective Chemotherapy on Prevalence and Intensity of Schistosoma Mansoni Infections in the Nile Delta: Kafr El Sheikh,” Tropical and Geographical Medicine 47: 266-270, 1995.

Cochrane, D. Glynn, and Bernhard H. Liese, “Egypt: Schistosomiasis Control,” in Organizing and Managing Tropical Disease Control Programmes: Case Studies, edited by Bernhard H. Liese, Paramjit S. Sachdeva, and D. Glynn Cochrane, Washington, D.C.: The World Bank, 1992:37-50.

Cole, Henry E., Robert H. Smith, and Sohair Sukkary, An Overview of Pharmacies, Pharmacists and the Pharmaceutical Distribution System in Egypt: An Executive Summary, Prepared for the US Agency for International Development, by the Futures Group, Washington, D.C., May 1982.

EIPICO, “Egyptian International Pharmaceutical Industries Co.,” brochure, 1989 (est.).

EIPICO, “Dear Doctor” letter, from Dr Hamdy Tawfik, Marketing Director, 1995 (est.).

El Khoby, Taha, Nabil Galal, and Alan Fenwick, “Schistosomiasis Control in Egypt,” Schistosomiasis Research Project 3(3):2, 1993.

El Malatawy, A., An Integrated Approach to Schistosomiasis Control. Unpublished document. Cairo: UNICEF, January 1989.

El Malatawy, A., A. El Habashy, N. Lechine, H. Dixon, A. Davis, and K.E. Mott, “Selective Population Chemotherapy Among Schoolchildren in Beheira Governorate: The UNICEF/Arab Republic of Egypt/WHO Schistosomiasis Control Project,” Bulletin of the World Health Organization 70:47-56, 1992.

El Shafei, N., The Pharmaceutical Industry in the Arab World & Egypt. Cairo: Corporate Banking Group, August 1990.

Farag, M. K., A.M. El-Shazly, M. T. Khashaba, et al., “Impact of the Current National Bilharzia Control Programme on the Epidemiology of Schistosomiasis Mansoni in an Egyptian Village,” Transactions of the Royal Society of Tropical Medicine & Hygiene 87: 250-253, 1993.

Gad, Zakaria, President of the Egyptian Syndicate of Pharmacists, Interview, 1995.

Mahfouz, Mahmoud, Health Policy and Annual Report, Cairo: Ministry of Health, July 1972.

Menas Associates, “Economy & Business: Pharmaceutical Industry Struggles with Price Controls,” Egypt Focus, December 1992.

“Ministry of Health Schistosomiasis Control Activities in Egypt,” Schistosomiasis Research Project 3(2):1-3, 1993.

Ministry of Health, The Golden Book (issued on the MOH’s 50th anniversary), Cairo: Ministry of Health, 1986.

Ravenholt, Betty Butler, and Susan Russell, Legal and Regulatory Environment Affecting Family Planning in Egypt. A Special Report Prepared for the National Population Council Under the OPTIONS II Project. Washington, D.C.: The Futures Group, December 1993.

Reich, Michael R., and Ali Swelam, “School Children’s Health Insurance in Egypt,” Boston: Harvard School of Public Health, Data for Decision-Making Project, 1994.

Thomas, L.G., Harold Lubell, and Richard Sines, “Price and Market Liberalization in Egypt: Pharmaceuticals, A Case Study,” submitted by Nathan Associates to the U.S. Agency for International Development and the Ministry of Economy and Foreign Trade, Government of Egypt, October 1994.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014